Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeArtio MedicalEndura Embolization Device Interim Study Highlighted at Neurovascular Conference

Endura Embolization Device Interim Study Highlighted at Neurovascular Conference

The Recent Presentation of Interim Nonclinical Study Results was Presented by Presented by Dr. Blaise Baxter, a Neurovascular and Peripheral Interventional Radiologist at the ABC-WIN Seminar in Val d'Isere, France

“The Endura Embolization Device covers the aneurysm neck and provides a platform to embolize the remainder of the aneurysm sac,” said Dr. Baxter, an investor and consultant to the Company. “I am pleased to be the first to present the Endura technology to my peers. It is exciting to have this promising option on the horizon, and I believe it has the potential to significantly improve outcomes for patients with cerebral aneurysms,” added Baxter.

The Endura Embolization System consists of a detachable accessory balloon and soft platinum coils. The combination of coils and a balloon has the potential to provide immediate cerebral aneurysm occlusion, reduce the risk of coil prolapse, and promote endothelialization of the aneurysm neck by presenting a flat, solid surface at the aneurysm neck. Funded by a Phase I SBIR grant from the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, the study compared the efficacy of the Endura Embolization System to coil-only treatments for the occlusion of aneurysms in a challenging model of terminal bifurcation aneurysms.

“We are pleased the Endura technology was presented at this year’s ABC-WIN conference which provided an excellent opportunity to engage with physicians,” said Dr. F. Nicholas Franano, President and CEO of Artio. “Many difficult clinical cases were presented, highlighting the challenges associated with current commercially available devices. The feedback received on the Endura System was very encouraging, and we are increasingly confident in the clinical and commercial potential of Artio’s aneurysm occlusion devices.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy